 | • レポートコード：20QY06-01646 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、クリグラーナジャー症候群用薬のグローバル市場について種類別（ALXN-1540、AT-342、HepaStem、その他）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・クリグラーナジャー症候群用薬市場の概要 ・世界の主要地域別クリグラーナジャー症候群用薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のクリグラーナジャー症候群用薬市場規模2015-2026：種類別（ALXN-1540、AT-342、HepaStem、その他） ・世界のクリグラーナジャー症候群用薬市場規模2015-2026：用途別（病院、クリニック、その他） ・クリグラーナジャー症候群用薬の北米市場規模2015-2020 ・クリグラーナジャー症候群用薬のヨーロッパ市場規模2015-2020 ・クリグラーナジャー症候群用薬の中国市場規模2015-2020 ・クリグラーナジャー症候群用薬の日本市場規模2015-2020 ・クリグラーナジャー症候群用薬の東南アジア市場規模2015-2020 ・クリグラーナジャー症候群用薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Audentes Therapeutics Inc、Genethon SA、International Stem Cell Corp、Promethera Biosciences SA） ・クリグラーナジャー症候群用薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・クリグラーナジャー症候群用薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Crigler-Najjar Syndrome Drug Market
The global Crigler-Najjar Syndrome Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Crigler-Najjar Syndrome Drug Scope and Market Size
The global Crigler-Najjar Syndrome Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Crigler-Najjar Syndrome Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Crigler-Najjar Syndrome Drug market is segmented into
ALXN-1540
AT-342
HepaStem
Others
Segment by Application, the Crigler-Najjar Syndrome Drug market is segmented into
Hospital
Clinic
Others
The Crigler-Najjar Syndrome Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Crigler-Najjar Syndrome Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Crigler-Najjar Syndrome Drug Market Share Analysis
Crigler-Najjar Syndrome Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Crigler-Najjar Syndrome Drug business, the date to enter into the Crigler-Najjar Syndrome Drug market, Crigler-Najjar Syndrome Drug product introduction, recent developments, etc.
The major vendors covered:
Audentes Therapeutics Inc
Genethon SA
International Stem Cell Corp
Promethera Biosciences SA
…
Table of Contents
1 Crigler-Najjar Syndrome Drug Market Overview
1.1 Crigler-Najjar Syndrome Drug Product Scope
1.2 Crigler-Najjar Syndrome Drug Segment by Type
1.2.1 Global Crigler-Najjar Syndrome Drug Sales by Type (2020-2026)
1.2.2 ALXN-1540
1.2.3 AT-342
1.2.4 HepaStem
1.2.5 Others
1.3 Crigler-Najjar Syndrome Drug Segment by Application
1.3.1 Global Crigler-Najjar Syndrome Drug Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Crigler-Najjar Syndrome Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Crigler-Najjar Syndrome Drug Sales Growth Rate (2015-2026)
1.4.2 Global Crigler-Najjar Syndrome Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Crigler-Najjar Syndrome Drug Price Trends (2015-2026)
2 Crigler-Najjar Syndrome Drug Estimate and Forecast by Region
2.1 Global Crigler-Najjar Syndrome Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Crigler-Najjar Syndrome Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Crigler-Najjar Syndrome Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Crigler-Najjar Syndrome Drug Revenue Market Share by Region (2015-2020)
2.3 Global Crigler-Najjar Syndrome Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Crigler-Najjar Syndrome Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Crigler-Najjar Syndrome Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Crigler-Najjar Syndrome Drug Estimates and Projections (2015-2026)
2.4.2 Europe Crigler-Najjar Syndrome Drug Estimates and Projections (2015-2026)
2.4.3 China Crigler-Najjar Syndrome Drug Estimates and Projections (2015-2026)
2.4.4 Japan Crigler-Najjar Syndrome Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Crigler-Najjar Syndrome Drug Estimates and Projections (2015-2026)
2.4.6 India Crigler-Najjar Syndrome Drug Estimates and Projections (2015-2026)
3 Global Crigler-Najjar Syndrome Drug Competition Landscape by Players
3.1 Global Top Crigler-Najjar Syndrome Drug Players by Sales (2015-2020)
3.2 Global Top Crigler-Najjar Syndrome Drug Players by Revenue (2015-2020)
3.3 Global Crigler-Najjar Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crigler-Najjar Syndrome Drug as of 2019)
3.4 Global Crigler-Najjar Syndrome Drug Average Price by Company (2015-2020)
3.5 Manufacturers Crigler-Najjar Syndrome Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Crigler-Najjar Syndrome Drug Players (Opinion Leaders)
4 Global Crigler-Najjar Syndrome Drug Market Size by Type
4.1 Global Crigler-Najjar Syndrome Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Crigler-Najjar Syndrome Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Crigler-Najjar Syndrome Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Crigler-Najjar Syndrome Drug Price by Type (2014-2020)
4.2 Global Crigler-Najjar Syndrome Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Crigler-Najjar Syndrome Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Crigler-Najjar Syndrome Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Crigler-Najjar Syndrome Drug Price Forecast by Type (2021-2026)
5 Global Crigler-Najjar Syndrome Drug Market Size by Application
5.1 Global Crigler-Najjar Syndrome Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Crigler-Najjar Syndrome Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Crigler-Najjar Syndrome Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Crigler-Najjar Syndrome Drug Price by Application (2015-2020)
5.2 Global Crigler-Najjar Syndrome Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Crigler-Najjar Syndrome Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Crigler-Najjar Syndrome Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Crigler-Najjar Syndrome Drug Price Forecast by Application (2021-2026)
3 North America Crigler-Najjar Syndrome Drug Market Facts & Figures
3.2 North America Crigler-Najjar Syndrome Drug Sales Market Share by Company (2015-2020)
3.3 North America Crigler-Najjar Syndrome Drug Sales Market Share by Type (2015-2020)
3.4 North America Crigler-Najjar Syndrome Drug Sales Market Share by Application (2015-2020)
4 Europe Crigler-Najjar Syndrome Drug Market Facts & Figures
4.2 Europe Crigler-Najjar Syndrome Drug Sales Market Share by Company (2015-2020)
4.3 Europe Crigler-Najjar Syndrome Drug Sales Market Share by Type (2015-2020)
4.4 Europe Crigler-Najjar Syndrome Drug Sales Market Share by Application (2015-2020)
5 China Crigler-Najjar Syndrome Drug Market Facts & Figures
5.2 China Crigler-Najjar Syndrome Drug Sales Market Share by Company (2015-2020)
5.3 China Crigler-Najjar Syndrome Drug Sales Market Share by Type (2015-2020)
5.4 China Crigler-Najjar Syndrome Drug Sales Market Share by Application (2015-2020)
6 Japan Crigler-Najjar Syndrome Drug Market Facts & Figures
6.2 Japan Crigler-Najjar Syndrome Drug Sales Market Share by Company (2015-2020)
6.3 Japan Crigler-Najjar Syndrome Drug Sales Market Share by Type (2015-2020)
6.4 Japan Crigler-Najjar Syndrome Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Crigler-Najjar Syndrome Drug Market Facts & Figures
7.2 Southeast Asia Crigler-Najjar Syndrome Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Crigler-Najjar Syndrome Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Crigler-Najjar Syndrome Drug Sales Market Share by Application (2015-2020)
8 India Crigler-Najjar Syndrome Drug Market Facts & Figures
8.2 India Crigler-Najjar Syndrome Drug Sales Market Share by Company (2015-2020)
8.3 India Crigler-Najjar Syndrome Drug Sales Market Share by Type (2015-2020)
8.4 India Crigler-Najjar Syndrome Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Crigler-Najjar Syndrome Drug Business
12.1 Audentes Therapeutics Inc
12.1.1 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Corporation Information
12.1.2 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Business Overview and Total Revenue
12.1.3 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Products Offered
12.1.5 Audentes Therapeutics Inc Recent Development
12.2 Genethon SA
12.2.1 Genethon SA Crigler-Najjar Syndrome Drug Corporation Information
12.2.2 Genethon SA Crigler-Najjar Syndrome Drug Business Overview and Total Revenue
12.2.3 Genethon SA Crigler-Najjar Syndrome Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Genethon SA Crigler-Najjar Syndrome Drug Products Offered
12.2.5 Genethon SA Recent Development
12.3 International Stem Cell Corp
12.3.1 International Stem Cell Corp Crigler-Najjar Syndrome Drug Corporation Information
12.3.2 International Stem Cell Corp Crigler-Najjar Syndrome Drug Business Overview and Total Revenue
12.3.3 International Stem Cell Corp Crigler-Najjar Syndrome Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 International Stem Cell Corp Crigler-Najjar Syndrome Drug Products Offered
12.3.5 International Stem Cell Corp Recent Development
12.4 Promethera Biosciences SA
12.4.1 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Corporation Information
12.4.2 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Business Overview and Total Revenue
12.4.3 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Promethera Biosciences SA Crigler-Najjar Syndrome Drug Products Offered
12.4.5 Promethera Biosciences SA Recent Development
…
13 Crigler-Najjar Syndrome Drug Manufacturing Cost Analysis
13.1 Crigler-Najjar Syndrome Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Crigler-Najjar Syndrome Drug
13.4 Crigler-Najjar Syndrome Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Crigler-Najjar Syndrome Drug Distributors List
14.3 Crigler-Najjar Syndrome Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Crigler-Najjar Syndrome Drug Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Crigler-Najjar Syndrome Drug Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Crigler-Najjar Syndrome Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Crigler-Najjar Syndrome Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Crigler-Najjar Syndrome Drug Sales Market Share by Region (2015-2020)
Table 6. Global Crigler-Najjar Syndrome Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Crigler-Najjar Syndrome Drug Revenue Share by Region (2015-2020)
Table 8. Global Crigler-Najjar Syndrome Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Crigler-Najjar Syndrome Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Crigler-Najjar Syndrome Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Crigler-Najjar Syndrome Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Crigler-Najjar Syndrome Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Crigler-Najjar Syndrome Drug Sales Share by Company (2015-2020)
Table 14. Global Crigler-Najjar Syndrome Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Crigler-Najjar Syndrome Drug Revenue Share by Company (2015-2020)
Table 16. Global Crigler-Najjar Syndrome Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crigler-Najjar Syndrome Drug as of 2019)
Table 17. Global Crigler-Najjar Syndrome Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Crigler-Najjar Syndrome Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Crigler-Najjar Syndrome Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Crigler-Najjar Syndrome Drug Players
Table 22. Global Crigler-Najjar Syndrome Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Crigler-Najjar Syndrome Drug Sales Share by Type (2015-2020)
Table 24. Global Crigler-Najjar Syndrome Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Crigler-Najjar Syndrome Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Crigler-Najjar Syndrome Drug Sales Share by Type (2021-2026)
Table 27. Global Crigler-Najjar Syndrome Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Crigler-Najjar Syndrome Drug Revenue Share by Type (2021-2026)
Table 29. Global Crigler-Najjar Syndrome Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Crigler-Najjar Syndrome Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Crigler-Najjar Syndrome Drug Sales Share by Application (2015-2020)
Table 32. Global Crigler-Najjar Syndrome Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Crigler-Najjar Syndrome Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Crigler-Najjar Syndrome Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Crigler-Najjar Syndrome Drug Sales Share by Application (2021-2026)
Table 36. Global Crigler-Najjar Syndrome Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Crigler-Najjar Syndrome Drug Revenue Share by Application (2021-2026)
Table 38. Global Crigler-Najjar Syndrome Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Crigler-Najjar Syndrome Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Crigler-Najjar Syndrome Drug Sales Market Share by Company (2015-2020)
Table 41. United States Crigler-Najjar Syndrome Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Crigler-Najjar Syndrome Drug Sales Market Share by Type (2015-2020)
Table 43. United States Crigler-Najjar Syndrome Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Crigler-Najjar Syndrome Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Crigler-Najjar Syndrome Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Crigler-Najjar Syndrome Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Crigler-Najjar Syndrome Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Crigler-Najjar Syndrome Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Crigler-Najjar Syndrome Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Crigler-Najjar Syndrome Drug Sales Market Share by Type (2015-2020)
Table 51. China Crigler-Najjar Syndrome Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Crigler-Najjar Syndrome Drug Sales Market Share by Company (2015-2020)
Table 53. China Crigler-Najjar Syndrome Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Crigler-Najjar Syndrome Drug Sales Market Share by Type (2015-2020)
Table 55. China Crigler-Najjar Syndrome Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Crigler-Najjar Syndrome Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Crigler-Najjar Syndrome Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Crigler-Najjar Syndrome Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Crigler-Najjar Syndrome Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Crigler-Najjar Syndrome Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Crigler-Najjar Syndrome Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Crigler-Najjar Syndrome Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Crigler-Najjar Syndrome Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Crigler-Najjar Syndrome Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Crigler-Najjar Syndrome Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Crigler-Najjar Syndrome Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Crigler-Najjar Syndrome Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Crigler-Najjar Syndrome Drug Sales Market Share by Application (2015-2020)
Table 69. India Crigler-Najjar Syndrome Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Crigler-Najjar Syndrome Drug Sales Market Share by Company (2015-2020)
Table 71. India Crigler-Najjar Syndrome Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Crigler-Najjar Syndrome Drug Sales Market Share by Type (2015-2020)
Table 73. India Crigler-Najjar Syndrome Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Crigler-Najjar Syndrome Drug Sales Market Share by Application (2015-2020)
Table 75. Audentes Therapeutics Inc Corporation Information
Table 76. Audentes Therapeutics Inc Description and Business Overview
Table 77. Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Audentes Therapeutics Inc Crigler-Najjar Syndrome Drug Product
Table 79. Audentes Therapeutics Inc Recent Development
Table 80. Genethon SA Corporation Information
Table 81. Genethon SA Description and Business Overview
Table 82. Genethon SA Crigler-Najjar Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Genethon SA Crigler-Najjar Syndrome Drug Product
Table 84. Genethon SA Recent Development
Table 85. International Stem Cell Corp Corporation Information
Table 86. International Stem Cell Corp Description and Business Overview
Table 87. International Stem Cell Corp Crigler-Najjar Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. International Stem Cell Corp Crigler-Najjar Syndrome Drug Product
Table 89. International Stem Cell Corp Recent Development
Table 90. Promethera Biosciences SA Corporation Information
Table 91. Promethera Biosciences SA Description and Business Overview
Table 92. Promethera Biosciences SA Crigler-Najjar Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Promethera Biosciences SA Crigler-Najjar Syndrome Drug Product
Table 94. Promethera Biosciences SA Recent Development
Table 95. Production Base and Market Concentration Rate of Raw Material
Table 96. Key Suppliers of Raw Materials
Table 97. Crigler-Najjar Syndrome Drug Distributors List
Table 98. Crigler-Najjar Syndrome Drug Customers List
Table 99. Market Key Trends
Table 100. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 101. Key Challenges
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Crigler-Najjar Syndrome Drug Product Picture
Figure 2. Global Crigler-Najjar Syndrome Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Crigler-Najjar Syndrome Drug Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Others Examples
Figure 9. Global Crigler-Najjar Syndrome Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Crigler-Najjar Syndrome Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Crigler-Najjar Syndrome Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Crigler-Najjar Syndrome Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Crigler-Najjar Syndrome Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Crigler-Najjar Syndrome Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Crigler-Najjar Syndrome Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Crigler-Najjar Syndrome Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Crigler-Najjar Syndrome Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Crigler-Najjar Syndrome Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Crigler-Najjar Syndrome Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Crigler-Najjar Syndrome Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Crigler-Najjar Syndrome Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Crigler-Najjar Syndrome Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Crigler-Najjar Syndrome Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Crigler-Najjar Syndrome Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Crigler-Najjar Syndrome Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Crigler-Najjar Syndrome Drug Players Market Share by Revenue in Crigler-Najjar Syndrome Drug 2015 & 2019
Figure 27. Crigler-Najjar Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Crigler-Najjar Syndrome Drug Revenue Share by Type (2015-2020)
Figure 29. Global Crigler-Najjar Syndrome Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Crigler-Najjar Syndrome Drug Revenue Share by Application (2015-2020)
Figure 31. Global Crigler-Najjar Syndrome Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Crigler-Najjar Syndrome Drug Sales Market Share by Type in 2019
Figure 33. United States Crigler-Najjar Syndrome Drug Sales Market Share by Type in 2019
Figure 34. Europe Crigler-Najjar Syndrome Drug Sales Market Share by Company in 2019
Figure 35. Europe Crigler-Najjar Syndrome Drug Sales Market Share by Type in 2019
Figure 36. Europe Crigler-Najjar Syndrome Drug Sales Market Share by Application in 2019
Figure 37. China Crigler-Najjar Syndrome Drug Sales Market Share by Company in 2019
Figure 38. China Crigler-Najjar Syndrome Drug Sales Market Share by Type in 2019
Figure 39. China Crigler-Najjar Syndrome Drug Sales Market Share by Application in 2019
Figure 40. Japan Crigler-Najjar Syndrome Drug Sales Market Share by Company in 2019
Figure 41. Japan Crigler-Najjar Syndrome Drug Sales Market Share by Type in 2019
Figure 42. Japan Crigler-Najjar Syndrome Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Crigler-Najjar Syndrome Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Crigler-Najjar Syndrome Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Crigler-Najjar Syndrome Drug Sales Market Share by Application in 2019
Figure 46. India Crigler-Najjar Syndrome Drug Sales Market Share by Company in 2019
Figure 47. India Crigler-Najjar Syndrome Drug Sales Market Share by Type in 2019
Figure 48. India Crigler-Najjar Syndrome Drug Sales Market Share by Application in 2019
Figure 49. Audentes Therapeutics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Genethon SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. International Stem Cell Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Promethera Biosciences SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Key Raw Materials Price Trend
Figure 54. Manufacturing Cost Structure of Crigler-Najjar Syndrome Drug
Figure 55. Manufacturing Process Analysis of Crigler-Najjar Syndrome Drug
Figure 56. Crigler-Najjar Syndrome Drug Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Porter's Five Forces Analysis
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
群発性頭痛症候群薬の世界市場レポート2020 Market Analysis and Insights: Global Cluster Headache Syndrome Drug Market The global Cluster Headache Syndrome Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Cluster Headache Syndrome Drug Scope an…- アスペルガー症候群治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Asperger Syndrome Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Asperger Syndrome…
- ランバートイートンミアステニックシンドローム（LEMS）治療の世界市場レポート2020 A recently published report by QY Research titled Global Lambert-Eaton Myasthenic Syndrome (LEMS) Therapeutics Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report a…
- 骨髄異形成症候群（MDS）薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Myelodysplastic Syndrome (MDS) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1798.3 million by 2025, from USD 1452.7 million in 2019. The…
- バーター症候群薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Bartter Syndrome Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bartter Syndrome Drugs…